RxDoctor Payments Data

Eyad Khabbaz, MD

Otolaryngology · Punxsutawney, PANPI 1417113085

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $12,552 of the $18,510 with a category attached, or 67.8%. 23 manufacturers reported payments, led by Smith+Nephew at 31.8% of the total. Reporting peaked in 2022 at $7,609 and has fallen 86.1% since, to $1,061 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,510in general payments, 2019–2025

Across 179 payments — averaging $103.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Medtronic$4K
  • Medical Device Business Services, Inc.$3K
  • Acclarent, Inc$2K
  • Stryker$1K
  • GSK$699
  • plus $3K from 17 others

What the payments were for

  • Speaking & faculty fees$1481%
  • Travel & lodging$12,55268%
  • Food & beverage$5,52330%
  • Education$2792%
  • Gifts$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,510 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$75,446
Medicare patients
307
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl102$2,064
Fluticasone Propionate186$1,691
Famotidine138$1,124
Mupirocin100$775
Ipratropium Bromide14$735
Fluocinolone Acetonide Oil18$663
Ofloxacin13$295
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$232
Montelukast Sodium11$67
Chlorhexidine Gluconate16$57
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$42

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Punxsutawney

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →